BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

750 related articles for article (PubMed ID: 19834878)

  • 1. Visfatin (nampt) and ghrelin as novel markers of carotid atherosclerosis in patients with type 2 diabetes.
    Kadoglou NP; Sailer N; Moumtzouoglou A; Kapelouzou A; Tsanikidis H; Vitta I; Karkos C; Karayannacos PE; Gerasimidis T; Liapis CD
    Exp Clin Endocrinol Diabetes; 2010 Feb; 118(2):75-80. PubMed ID: 19834878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of atorvastatin on apelin, visfatin (nampt), ghrelin and early carotid atherosclerosis in patients with type 2 diabetes.
    Kadoglou NP; Sailer N; Kapelouzou A; Lampropoulos S; Vitta I; Kostakis A; Liapis CD
    Acta Diabetol; 2012 Aug; 49(4):269-76. PubMed ID: 21748474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus.
    Kadoglou NP; Tsanikidis H; Kapelouzou A; Vrabas I; Vitta I; Karayannacos PE; Liapis CD; Sailer N
    Metabolism; 2010 Mar; 59(3):373-9. PubMed ID: 19815243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of hemodialysis on accelerated atherosclerosis in diabetic patients: correlation of carotid artery intima-media thickness with oxidative stress.
    Dursun B; Dursun E; Suleymanlar G; Ozben B; Capraz I; Apaydin A; Ozben T
    J Diabetes Complications; 2009; 23(4):257-64. PubMed ID: 18413174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The possible correlation between serum GRB2 levels and carotid atherosclerosis in patients with type 2 diabetes mellitus.
    Dong Y; Liu J; Ma J; Quan J; Bao Y; Cui Y
    Front Endocrinol (Lausanne); 2022; 13():963191. PubMed ID: 36176460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between elevated visfatin and carotid atherosclerosis in patients with chronic kidney disease.
    Tang X; Chen M; Zhang W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Jun; 38(6):553-9. PubMed ID: 23828708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein as a marker of progression of carotid atherosclerosis in subjects with type 2 diabetes mellitus.
    Pleskovič A; Letonja MŠ; Vujkovac AC; Nikolajević Starčević J; Gazdikova K; Caprnda M; Gaspar L; Kruzliak P; Petrovič D
    Vasa; 2017 May; 46(3):187-192. PubMed ID: 28218562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating levels of adipose tissue-derived inflammatory factors in elderly diabetes patients with carotid atherosclerosis: a retrospective study.
    Yang W; Li Y; Wang JY; Han R; Wang L
    Cardiovasc Diabetol; 2018 May; 17(1):75. PubMed ID: 29848323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy.
    Alghasham AA; Barakat YA
    Saudi Med J; 2008 Feb; 29(2):185-92. PubMed ID: 18246224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma des-acyl ghrelin, but not plasma HMW adiponectin, is a useful cardiometabolic marker for predicting atherosclerosis in elderly hypertensive patients.
    Yano Y; Toshinai K; Inokuchi T; Kangawa K; Shimada K; Kario K; Nakazato M
    Atherosclerosis; 2009 Jun; 204(2):590-4. PubMed ID: 19041092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms XbaI (rs693) and EcoRI (rs1042031) of the ApoB gene are associated with carotid plaques but not with carotid intima-media thickness in patients with diabetes mellitus type 2.
    Nikolajevic Starcevic J; Santl Letonja M; Praznikar ZJ; Makuc J; Vujkovac AC; Petrovic D
    Vasa; 2014 May; 43(3):171-80. PubMed ID: 24797048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between plasma antioxidant concentrations and carotid intima-media thickness: the Asymptomatic Carotid Atherosclerotic Disease In Manfredonia Study.
    Riccioni G; D'Orazio N; Palumbo N; Bucciarelli V; Ilio Ed; Bazzano LA; Bucciarelli T
    Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):351-7. PubMed ID: 19384236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early atherosclerosis in ulcerative colitis: cross-sectional case-control study.
    Jain SS; Shah DK; Gambhire PA; Varma RU; Contractor QQ; Rathi PM
    J Dig Dis; 2015 Nov; 16(11):656-64. PubMed ID: 26512945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carotid intima-media thickness among normoglycemia and normotension first-degree relatives of type 2 diabetes mellitus.
    Purnamasari D; Abdaly MS; Azizi MS; Wijaya IP; Nugroho P
    Vasc Health Risk Manag; 2019; 15():101-107. PubMed ID: 31190848
    [No Abstract]   [Full Text] [Related]  

  • 15. Mean Platelet Volume Is Closely Associated With Serum Glucose Level but Not With Arterial Stiffness and Carotid Atherosclerosis in Patients With Type 2 Diabetes.
    Kim ES; Mo EY; Moon SD; Han JH
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3502-8. PubMed ID: 26120789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carotid intima-media thickness: an index for subclinical atherosclerosis in type 1 diabetes.
    Abdelghaffar S; El Amir M; El Hadidi A; El Mougi F
    J Trop Pediatr; 2006 Feb; 52(1):39-45. PubMed ID: 16000343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between glucose fluctuations and carotid intima-media thickness in type 2 diabetes.
    Chen XM; Zhang Y; Shen XP; Huang Q; Ma H; Huang YL; Zhang WQ; Wu HJ
    Diabetes Res Clin Pract; 2010 Oct; 90(1):95-9. PubMed ID: 20605247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased carotid intima-media thickness in pre-pubertal children with constitutional leanness and severe obesity: the speculative role of insulin sensitivity, oxidant status, and chronic inflammation.
    Giannini C; de Giorgis T; Scarinci A; Cataldo I; Marcovecchio ML; Chiarelli F; Mohn A
    Eur J Endocrinol; 2009 Jul; 161(1):73-80. PubMed ID: 19423560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum CXC ligand 5 is a new marker of subclinical atherosclerosis in type 2 diabetes.
    Chen L; Yang Z; Lu B; Li Q; Ye Z; He M; Huang Y; Wang X; Zhang Z; Wen J; Liu C; Qu S; Hu R
    Clin Endocrinol (Oxf); 2011 Dec; 75(6):766-70. PubMed ID: 21609350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes.
    Xiao Y; Liu L; Xu A; Zhou P; Long Z; Tu Y; Chen X; Tang W; Huang G; Zhou Z
    Cardiovasc Diabetol; 2015 Jun; 14():72. PubMed ID: 26047614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.